U.S. flag

An official website of the United States government

NM_004082.5(DCTN1):c.414+1G>A AND DCTN1-related disorder

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 27, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004529462.1

Allele description [Variation Report for NM_004082.5(DCTN1):c.414+1G>A]

NM_004082.5(DCTN1):c.414+1G>A

Gene:
DCTN1:dynactin subunit 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p13.1
Genomic location:
Preferred name:
NM_004082.5(DCTN1):c.414+1G>A
HGVS:
  • NC_000002.12:g.74376741C>T
  • NG_008735.2:g.20347G>A
  • NM_001135040.3:c.393+691G>A
  • NM_001190836.2:c.342+691G>A
  • NM_001190837.2:c.393+691G>A
  • NM_001378991.1:c.363+1G>A
  • NM_001378992.1:c.363+1G>A
  • NM_004082.5:c.414+1G>AMANE SELECT
  • LRG_237t1:c.414+1G>A
  • LRG_237:g.20347G>A
  • NC_000002.11:g.74603868C>T
  • NM_004082.4:c.414+1G>A
Links:
dbSNP: rs576198476
NCBI 1000 Genomes Browser:
rs576198476
Molecular consequence:
  • NM_001135040.3:c.393+691G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001190836.2:c.342+691G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001190837.2:c.393+691G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001378991.1:c.363+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_001378992.1:c.363+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]
  • NM_004082.5:c.414+1G>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:
DCTN1-related disorder
Synonyms:
DCTN1-related condition
Identifiers:

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000915927Illumina Laboratory Services, Illumina
criteria provided, single submitter

(ICSL Variant Classification Criteria 09 May 2019)
Uncertain significance
(Apr 27, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Laboratory Services, Illumina, SCV000915927.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The DCTN1 c.414+1G>A variant occurs in a canonical splice site (donor) and is therefore predicted to disrupt or distort the normal gene product. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. The variant is reported at a frequency of 0.00004 in the Total population from the 1000 Genomes Project, the Exome Sequencing Project, or the Exome Aggregation Consortium. Based on the variant frequency, disease prevalence, disease penetrance, and inheritance mode, this variant could not be ruled out of causing disease. Due to the potential impact of splice donor variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for DCTN1-related disorders. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024